Alector stock plummets 13% as GSK terminates neuroscience pact (GSK:NYSE)
Finance Desk
Wirestock
Alector (ALEC) Wednesday said that GSK had terminated their neuroscience collaboration deal covering two experimental antibody drugs after both the drug candidates suffered clinical setbacks. Alector (ALEC) shares dropped 13% in extended trading, GSK eased 1.5%.
